Showing results (141-150 of 660) with videos related to
Sort By:
Pageof 66
Nature Cancer|August 7, 2023
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cellsWeiwei Wu, Tiongsun Chia, Jia Lu, et al.Nature Cancer|August 7, 2023
Different niches for stem cells carrying the same oncogenic driver affect pathogenesis and therapy response in myeloproliferative neoplasmsElodie Grockowiak, Claudia Korn, Justyna Rak, et al.Nature Cancer|July 31, 2023
Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanomaRenáta Váraljai, Lisa Zimmer, Yahya Al-Matary, et al.Nature Cancer|July 10, 2023
ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancerInes Mota, Enrico Patrucco, Cristina Mastini, et al.Nature Cancer|June 19, 2023
c-Kit signaling potentiates CAR T cell efficacy in solid tumors by CD28- and IL-2-independent co-stimulationYuquan Xiong, Meriem Taleb, Kyohei Misawa, et al.Nature Cancer|June 12, 2023
Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancerChanghwan Sung, Jinhyeon An, Soohyeon Lee, et al.Nature Cancer|July 15, 2026
Immune implications and therapeutic opportunities of tumor glycosylationRemi Hatinguais, Stan Verjans, Joana Gomes, et al.Nature Cancer|June 26, 2026
Inhibition of ADSS2-mediated de novo AMP biosynthesis re-sensitizes acute myeloid leukemia to BH3 mimeticsXin He, Lei Zhang, Yang Li, et al.Nature Cancer|July 1, 2026
IDH1-mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trialLukas Bunse, Katharina Lindner, Antje Wick, et al.Nature Cancer|July 9, 2026
A micropeptide encoded by the lncRNA USP30-AS1 promotes tumor growth by attenuating cGAS-STING-type I IFN signaling in macrophagesXingwen Wang, Yi Zhang, Jiangwen Ma, et al.Pageof 66